Clinical Trial Update: Lenalidomide and Rituximab in the Treatment of Relapsed Mantle Cell Lymphoma (MCL) and Diffuse Large B-Cell Lymphoma [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 study evaluating lenalidomide plus rituximab in relapsed mantle cell lymphoma and diffuse large B-cell lymphoma; trial completed with results posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• Mantle Cell Lymphoma

Drugs mentioned

• Lenalidomide (lenalidomide)
• Rituximab (rituximab)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-02-24